Industry Experts - Market Research

Global Advanced Drug Delivery Systems (ADDS) Market is Anticipated to Touch $395 billion by 2030, Owing to Increased Incidence of Chronic Diseases and Rising Demand for Personalized Medicine

Wednesday Apr 09, 2025

The latest version of the report from Industry Experts Inc, on "Advanced Drug Delivery Systems (ADDS) Market," is introduced. According to this global market research report, estimated at US$277 billion in 2024, the global ADDS market size is projected to reach above US$395 billion by 2030, growing at a CAGR of 6.1% between 2024 and 2030.

The Advanced Drug Delivery Systems (ADDS) market is growing significantly due to the increasing incidence of chronic diseases, technological advancements, and the rising demand for personalized medicine. ADDS enhance drug release, boost bioavailability, and facilitate targeted delivery, leading to improved therapeutic results while reducing side effects. The role of nanotechnology is crucial, as nanoparticles allow for accurate drug delivery for illnesses such as cancer and cardiovascular and neurological disorders. Biologics and gene therapies create new treatment options using viral vectors and lipid nanoparticles, particularly for genetic and chronic conditions. Implantable devices provide continuous drug release, which enhances patient adherence to long-term therapy.

North America dominates the global Advanced Drug Delivery Systems (ADDS) market, capturing 39.5% of the share in 2024. This dominance is due to the robust pharmaceutical sector, rapid approval of advanced drug delivery technologies, and substantial healthcare expenditures. The U.S. is at the forefront of this region, bolstered by advancements in injectable systems, a rising incidence of chronic diseases, and an increased inclination towards self-administration. In contrast, the Asia-Pacific region is projected to be the fastest-growing region, exhibiting a 7.6% CAGR during the period 2024-2030, propelled by enhanced investments in healthcare, a vast patient demographic, and R&D initiatives supported by the government.

The market for ADDS analyzed in this report on a global basis covering all major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.

The study analyzes the global market for ADDS with respect to Route of Administration – Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others (Including Topical, Transdermal, Ocular & Otic, Targeted Delivery, Bioadhesive, and Hybrid Systems); Vehicle/Carrier Type – Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Therapeutics, Prodrugs, Microparticles and Other Vehicle/Carrier Types (Including Hydrogels, Implants, Viral Vectors, and Dendrimers); and Application – Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases and Allergies and Other Applications (Including Diabetes, Urology, Gastrointestinal (GI) Disorders, Dermatology, Hormone Replacement Therapy and Gynecology).

About Industry Experts, Inc
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/